The latest issue of Biotechnology Focus provides a detailed update on the work that Clinical Trials Ontario (CTO) is doing to enhance the clinical trial environment in Ontario and Canada.
CTO figures prominently in the article, “The Evolving Clinical Trial Landscape in Canada-An Update,” written by Diane Gajewczyk.
“A quick pulse check of the Canadian clinical trial environment, and specifically the work of CTO seems to indicate that we are strategically on the right path, but, more importantly, the strategy is being implemented,” she writes.